top of page
9a3401443424e5ae369bc5b8efacdb6c71d6d868-1600x1066.jpg

Under the auspices of 

IFCC logo - Rev. 0.tif
Jan 14-16, 2027 in Phoenix, AZ

THE 3RD SUMMIT OF LABORATORY & MEDICINE INNOVATIONS 
 

ORGANIZING COMMITTEE

The 2027 meeting is hosted by Alliance for Laboratory Medicine Innovation (ALMI), supported by Foundation for Laboratory Medicine Innovation (FLMI).

Meeting Chair: Zhen Zhao, PhD, DABCC, Weill Cornell Medicine

Executive Chair: Jing Cao, PhD, DABCC, University fo Texas Southwestern Medical Center

Scientific Chair: Xin Yi, PhD, DABCC, Houston Methodist Hospital

Program Planning and Strategic Chair: Min Yu, MD, PhD, MBA, DABCC,  Harvard Beth Israel Deaconess Medical Center

Section Chairs: ​

Genomics and Personalized Diagnostics: Zhenya Tang, MD, PhD, FACMG, University of Nebraska Medical Center

Transplant Precision Medicine: Dongfeng Chen, PhD, F(ACHI), Duke University Medical Center

Drug Use and Misuse: Yanwei Xi, DABMGG, FACMG, Children's Hospital of Eastern Ontario;

                                                     Fang Wu, PhD, DABCC, Harvard Brigham and Women’s Hospital

From AI to Advanced Diagnostics: Sabrina Racine-Brzostek, MD, Weill Cornell Medicine​

Bioengineering in Clinical Applications: Chao Wang,  PhD, Arizona State University

From Technology to Clinical Solutions: Lingjun Li, PhD, The University of Wisconsin-Madison

FDA Regulation and Policy: Jinjie Hu, PhD, President, Axteria BioMed Consulting Inc.; CEO, ClearDx Labs

Intellectual Property & Patent: Lukas Pfannenstiel, PhD, Saul Ewing 

Commercial Laboratory: Genomics and Metagenomics in Oncology: Xie Heng, PhD, MBA, Delve Bio

At-Home and Direct to Consumer Testing: Nicole Tolan, PhD, DABCC, Washington University

Human Microbiome and Infectious Disease: Stefan Riedel, MD, PhD, Beth Israel Deaconess Medical Center, Harvard Medical School

Cardiac Health & Chronic Disease Monitoring: Jing Cao, PhD, DABCC, University fo Texas Southwestern Medical Center

bottom of page